IMMUNIC, INC. — Director's Dealing 2021

Aug 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2021-08-10

Reporting Person: Whaley Glenn (PFO and PAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-10	Common Stock	P	1500	$9.85	Acquired	3500	Direct

Footnotes

F1: Reflects the weighted average price of 1,500 shares of common stock of Immunic, Inc. purchased by the Reporting Person in multiple transactions on August 10, 2021 at prices ranging from $9.65 to $9.95 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.